Anthropic reportedly booked more than $660 million in non-cash expense over six months for stock used to match employee charitable donations, putting an unusual equity program under greater scrutiny as the Claude maker moves toward a possible public listing.
The figure covers the period from October 2025 through March 2026, according to reporting summarized by AI Weekly from The Information. The first-quarter portion alone was about $125 million, or roughly 10% of employee expenses and 2% of operating costs for the period.
The important accounting point is that “non-cash expense” does not mean Anthropic wrote charities checks totaling the same amount. The reported program involves stock matching: employees donate equity or make qualifying charitable gifts, and the company provides matching stock. Accounting recognizes an expense tied to that equity even though the company does not necessarily transfer an equivalent amount of cash out of its bank account.
That does not make the cost imaginary. When a company issues or allocates additional shares, the economic burden can fall on existing owners through dilution. If an investor owns 1% of a company and the total share count rises while that investor’s holdings stay unchanged, the investor’s percentage ownership falls. The effect can matter even when cash remains on the balance sheet.
That distinction becomes more visible around an initial public offering because public investors tend to evaluate companies on a per-share basis. Repeated stock issuance for compensation, acquisitions or charitable matching can increase the number of shares over which a company’s future earnings and value are spread.
Anthropic confidentially submitted IPO paperwork in June 2026, according to Forge's IPO timeline, although confidential filing does not guarantee that a listing will occur on a particular date or at a particular valuation. The company can still change its plans, and final offering terms remain subject to the regulatory process and market conditions.
The charity program is drawing attention because its reported scale is already large before a public debut. Reporting cited by AI Weekly projects that the expense could climb into the billions after an IPO and dilute other shareholders. That is a forward-looking estimate, not a historical bill Anthropic has already incurred.
Future cost will depend on variables that are not fixed today: Anthropic’s eventual share price, the volume of eligible employee donations, the terms of the matching program, the number of shares issued or reserved and any changes the company makes after becoming public. A higher stock price could make the accounting value of matching equity much larger without requiring a matching increase in cash spending.
The issue also illustrates why adjusted financial measures can become contentious before an IPO. Companies often separate stock-based expenses from some non-GAAP measures because those costs do not consume cash in the same way as salaries, rent or compute bills. Investors may still care about them because dilution changes the economics of each share.
In Anthropic’s case, the charitable purpose adds another layer. The program can direct substantial value to nonprofits while helping employees amplify their giving. From a shareholder perspective, however, the motive does not change the dilution mechanics: additional equity distributed outside the existing shareholder base can reduce existing owners’ proportional stake.
The most misleading way to describe the story would be to say Anthropic has already “spent billions” on charity. The reported historical figure is more than $660 million in non-cash expense over six months. The multibillion-dollar number is a projection for what the program could become after an IPO, and the shareholder effect is primarily about equity dilution rather than an equivalent cash drain.
That distinction is likely to matter more as Anthropic reveals more financial detail. A public filing would give investors a clearer view of how the matching program is structured, how the company accounts for it and how much additional equity it expects to issue. Until then, the reported charge is significant evidence of scale, while the eventual post-IPO cost remains an estimate rather than a settled bill.
